“…Uncovering molecular communications between a bone tissue model and other organs or tissues, such as muscle (Brotto & Bonewald, ; Karsenty & Mera, ; Maurel, Jahn, & Lara‐Castillo, ), pancreas (Faienza et al, ; Shirakawa, De Jesus, & Kulkarni, ), liver (Collier, ), kidney (Vervloet et al, ), intestine (Keller & Schinke, ), stomach (McCabe & Parameswaran, ), thyroid and adrenal glands (Rockville, ), and lymphoid tissue (Sato et al, ), could contribute to a better understanding of the endocrine functions of human bone tissue (Zaidi et al, ), bone remodeling, and associated diseases (Maurel et al, ; Owen & Reilly, ). These combinations of tissue models could also be used as operative platforms for the evaluation of the efficacy, safety, and toxicity of drug candidates (Edington et al, ; Ishida, ; Kimura, Sakai, & Fujii, ; Tetsuka, Ohbuchi, & Tabata, ) and medical devices (Guan et al, ), potentially boosting research time and cost efficiency while coming into the scope of the 3Rs principles (replace, reduce, and refine). Although the opportunities offered by these models are game‐changing, published proof‐of‐concept studies and prototypes have yet to switch from technology research to actual biological, clinical, and biomedical applications (Junaid et al, ; Kimura et al, ).…”